Literature DB >> 23470427

Analytical and clinical validation of the Immulite 1000 hCG assay for quantitative analysis in urine.

Frances L Cate1, Courtney Moffett, Ann M Gronowski, David G Grenache, Katherine E Hartmann, Alison Woodworth.   

Abstract

BACKGROUND: The Siemens Immulite hCG assay detects all major hCG variants in serum. Currently, this assay is only FDA approved for qualitative measurement of hCG in urine.
METHODS: Complete validation of the hCG assay in urine was performed on the Siemens Immulite 1000 immunoassay platform. Reference intervals were established for females <55 y, females ≥55 y, and males 20-70 y.
RESULTS: The limit of quantitation was 2.0 IU/l. The Immulite hCG assay was precise for measuring hCG in urine from pregnant patients with intra- and inter-assay imprecision of <11% CV. The assay was linear over a dynamic range of 2-2600 IU/l and 2-3500 IU/l for hCG and hCGβ respectively. The assay was non-linear for hCGβcf. No hook effect was observed at concentrations up to 1,200,000 pmol/l, for hCGβ or hCGβcf. The reference intervals were <2.0 IU/l for males, <2.2I U/l for females <55 y, and <12.2I U/l for females ≥55 y.
CONCLUSION: The Immulite 1000 hCG assay can accurately quantify hCG in urine.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23470427      PMCID: PMC3856699          DOI: 10.1016/j.cca.2013.02.026

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  16 in total

1.  Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy.

Authors:  Ruth McChesney; Allen J Wilcox; John F O'Connor; Clarice R Weinberg; Donna D Baird; John P Schlatterer; D Robert McConnaughey; Steven Birken; Robert E Canfield
Journal:  Hum Reprod       Date:  2005-01-21       Impact factor: 6.918

Review 2.  The classification, functions and clinical use of different isoforms of HCG.

Authors:  Ulf-Håkan Stenman; Aila Tiitinen; Henrik Alfthan; Leena Valmu
Journal:  Hum Reprod Update       Date:  2006-07-28       Impact factor: 15.610

3.  Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women.

Authors:  Jennifer A Snyder; Shannon Haymond; Curtis A Parvin; Ann M Gronowski; David G Grenache
Journal:  Clin Chem       Date:  2005-08-11       Impact factor: 8.327

4.  Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG.

Authors:  G Kovalevskaya; S Birken; T Kakuma; J F O'Connor
Journal:  J Endocrinol       Date:  1999-04       Impact factor: 4.286

5.  Hourly human chorionic gonadotropin secretion profiles during the peri-implantation period of successful pregnancies.

Authors:  Pete N Lohstroh; James W Overstreet; Dennis R Stewart; Steven T Nakajima; Jeffrey R Cragun; Stephen P Boyers; Bill L Lasley
Journal:  Fertil Steril       Date:  2007-01-29       Impact factor: 7.329

6.  Limitations in qualitative point of care hCG tests for detecting early pregnancy.

Authors:  Dina N Greene; Robert L Schmidt; Sandy M Kamer; David G Grenache; Carolyn Hoke; Thomas S Lorey
Journal:  Clin Chim Acta       Date:  2012-11-15       Impact factor: 3.786

7.  False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.

Authors:  Ann M Gronowski; Mark Cervinski; Ulf-Håkan Stenman; Alison Woodworth; Lori Ashby; Mitchell G Scott
Journal:  Clin Chem       Date:  2009-04-24       Impact factor: 8.327

Review 8.  Human chorionic gonadotropin in cancer.

Authors:  Ulf-Håkan Stenman; Henrik Alfthan; Kristina Hotakainen
Journal:  Clin Biochem       Date:  2004-07       Impact factor: 3.281

Review 9.  Gonadotropins in doping: pharmacological basis and detection of illicit use.

Authors:  U-H Stenman; K Hotakainen; H Alfthan
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

10.  The need for a quantitative urine hCG assay.

Authors:  Laurence A Cole; Sarah A Khanlian
Journal:  Clin Biochem       Date:  2008-11-06       Impact factor: 3.281

View more
  1 in total

1.  A Point-of-Care Immunosensor for Human Chorionic Gonadotropin in Clinical Urine Samples Using a Cuneated Polysilicon Nanogap Lab-on-Chip.

Authors:  S R Balakrishnan; U Hashim; Subash C B Gopinath; P Poopalan; H R Ramayya; M Iqbal Omar; R Haarindraprasad; P Veeradasan
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.